Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wojnowski

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 20, 2010
Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4)G Spanier, H Xu, N Xia, et al.
Nature Genetics|July 1, 1997
Endothelial apoptosis in Braf-deficient miceL Wojnowski, A M Zimmer, T W Beck, et al.
Genes and Immunity|January 12, 2007
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphomaD Kube, T-D Hua, M Klöss, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 13, 2006
Marmoset CYP3A21, a model for human CYP3A4: protein expression and functional characterization of the promoterS C Koehler, N Von Ahsen, C Schlumbohm, et al.
Mechanisms of Development|October 10, 1998
Craf-1 protein kinase is essential for mouse developmentL Wojnowski, L F Stancato, A M Zimmer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4E Hustert, A Zibat, E Presecan-Siedel, et al.
Pharmacogenetics and Genomics|December 14, 2005
Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populationsMarkus Schirmer, Mohammad R Toliat, Michael Haberl, et al.
The Journal of Biological Chemistry|July 8, 2000
Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcomaH Hahn, L Wojnowski, K Specht, et al.
Pharmacogenetics|December 12, 2001
The genetic determinants of the CYP3A5 polymorphismE Hustert, M Haberl, O Burk, et al.
Pharmacogenetics|July 27, 2001
Identification and functional characterization of eight CYP3A4 protein variantsR Eiselt, T L Domanski, A Zibat, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 20, 2010
Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4)G Spanier, H Xu, N Xia, et al.
Nature Genetics|July 1, 1997
Endothelial apoptosis in Braf-deficient miceL Wojnowski, A M Zimmer, T W Beck, et al.
Genes and Immunity|January 12, 2007
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphomaD Kube, T-D Hua, M Klöss, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 13, 2006
Marmoset CYP3A21, a model for human CYP3A4: protein expression and functional characterization of the promoterS C Koehler, N Von Ahsen, C Schlumbohm, et al.
Mechanisms of Development|October 10, 1998
Craf-1 protein kinase is essential for mouse developmentL Wojnowski, L F Stancato, A M Zimmer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4E Hustert, A Zibat, E Presecan-Siedel, et al.
Pharmacogenetics and Genomics|December 14, 2005
Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populationsMarkus Schirmer, Mohammad R Toliat, Michael Haberl, et al.
The Journal of Biological Chemistry|July 8, 2000
Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcomaH Hahn, L Wojnowski, K Specht, et al.
Pharmacogenetics|December 12, 2001
The genetic determinants of the CYP3A5 polymorphismE Hustert, M Haberl, O Burk, et al.
Pharmacogenetics|July 27, 2001
Identification and functional characterization of eight CYP3A4 protein variantsR Eiselt, T L Domanski, A Zibat, et al.
Pageof 4